


Healthcare News Roundup: FDA
HSMN NewsFeed - 24 Dec 2013
Atossa Genetics Submits Premarket 510(k) Notification for ForeCYTE Breast Aspirator
Atossa Genetics Submits Premarket 510(k) Notification for ForeCYTE Breast Aspirator
HSMN NewsFeed - 20 Dec 2013
Endologix Receives IDE Approval for the Nellix(R) EndoVascular Aneurysm Sealing System
Endologix Receives IDE Approval for the Nellix(R) EndoVascular Aneurysm Sealing System
HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
HSMN NewsFeed - 11 Dec 2013
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
HSMN NewsFeed - 9 Dec 2013
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab
HSMN NewsFeed - 27 Nov 2013
Elekta Receives US FDA 510(k) Clearance for its Monaco 5 Treatment Planning System
Elekta Receives US FDA 510(k) Clearance for its Monaco 5 Treatment Planning System
HSMN NewsFeed - 27 Nov 2013
CMC Contrast Granted Orphan Drug Designation by the FDA for its Liver Specific MRI Contrast Media CMC-001
CMC Contrast Granted Orphan Drug Designation by the FDA for its Liver Specific MRI Contrast Media CMC-001
HSMN NewsFeed - 26 Nov 2013
FDA Approves Varithena(TM) (Polidocanol Injectable Foam) for the Treatment of Patients with Varicose Veins
FDA Approves Varithena(TM) (Polidocanol Injectable Foam) for the Treatment of Patients with Varicose Veins
HSMN NewsFeed - 21 Nov 2013
Dallen Medical Receives FDA 510(k) Clearance for Its Tensyn(TM) Band for Syndesmosis Repair
Dallen Medical Receives FDA 510(k) Clearance for Its Tensyn(TM) Band for Syndesmosis Repair
HSMN NewsFeed - 21 Nov 2013
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine
Forest Laboratories and Gedeon Richter Receive Complete Response Letter for Cariprazine
HSMN NewsFeed - 20 Nov 2013
TauTona Group Receives FDA 510(k) Clearance and Key Patent for 'TauTona Tissue Injector'
TauTona Group Receives FDA 510(k) Clearance and Key Patent for 'TauTona Tissue Injector'
HSMN NewsFeed - 18 Nov 2013
Actinium Pharmaceuticals Announces Plans For Iomab(TM)-B Phase 3 Pivotal Trial Following Meeting With FDA
Actinium Pharmaceuticals Announces Plans For Iomab(TM)-B Phase 3 Pivotal Trial Following Meeting With FDA
